ArticleHuman molecular genetics2022

Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia.

Martina Di Rocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.